Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises bong in connection with new issues
Mandate

Vinge advises bong in connection with new issues

October 14, 2013

Bong AB (publ) (NASDAQ OMX Stockholm) has carried out a fully underwritten rights issue, a directed placement of convertible bonds to certain qualifying investors and set-off issues to certain creditors. The aggregate amount issued is approximately SEK 475 million.  Vinge advised Bong.

Vinge’s team primarily consisted of Erik Sjöman, Peter Oscarsson, Christian Lindhé, Fabian Ekeblad, Albert Wållgren and Henrik Jonsson.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026